Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-12
DOI
10.1038/s41598-017-03982-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin
- (2016) Peter Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CdtR Regulates TcdA and TcdB Production in Clostridium difficile
- (2016) Shelley A. Lyon et al. PLoS Pathogens
- The Monoclonal Antitoxin Antibodies (Actoxumab–Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection
- (2016) Mária Džunková et al. Frontiers in Cellular and Infection Microbiology
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- Emergence of toxin A-negative, toxin B-positive Clostridium difficile strains: epidemiological and clinical considerations
- (2015) Amy M King et al. Future Microbiology
- Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
- (2015) Glen P. Carter et al. mBio
- The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins
- (2015) Shuyi Chen et al. Toxins
- Clostridium difficile and the microbiota
- (2014) Anna M. Seekatz et al. JOURNAL OF CLINICAL INVESTIGATION
- Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection
- (2014) J. K. Sponseller et al. JOURNAL OF INFECTIOUS DISEASES
- Systemically Administered IgG Anti-Toxin Antibodies Protect the Colonic Mucosa during Infection with Clostridium difficile in the Piglet Model
- (2014) Ocean R. Cohen et al. PLoS One
- Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
- (2013) Sarah A. Kuehne et al. JOURNAL OF INFECTIOUS DISEASES
- Hyperimmune bovine colostrum for treatment of GI infections
- (2013) Jennifer Steele et al. Human Vaccines & Immunotherapeutics
- Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease
- (2012) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- TcdB or not TcdB: a tale of twoClostridium difficiletoxins
- (2011) Glen P Carter et al. Future Microbiology
- Systemic Dissemination of Clostridium difficile Toxins A and B Is Associated With Severe, Fatal Disease in Animal Models
- (2011) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile
- (2011) Glen P. Carter et al. PLoS Pathogens
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial
- (2008) Eero Mattila et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More